TOKYO—Hoya Corp. (TOKYO: 7741) reported sales of 127,645 million yen for the third quarter ended Dec. 31, 2015, a 0.4 percent decrease from the same period last year. Pre-tax profit for the quarter was 31,179 million yen, while profit for the quarter was 24,034 million yen, a decrease of 14.0 percent and 17.5 percent respectively from last year when foreign exchange gain was reported.

Sales for Hoya’s Life Care segment, which consists of its eyeglass lens, contact lens, and intraocular lens businesses and accounts for 63 percent of its revenue, totaled 80,331 million yen, 0.8 percent higher than the same period the previous year.

Although Hoya contact lens retail business reported a major increase for the quarter, eyeglass lens sales decreased slightly due to the negative impact of the foreign currency trends, according to Hoya. In the medical related products, sales of intraocular lens business for the cataract surgery rose substantially because of recovery in the Japanese market and success in developing sales overseas markets, while sales of medical endoscopes weakened, the company said. As a consequence, overall sales in the Life Care segment were flat.

For the nine months ended Dec. 31, 2015, Hoya posted record revenues of 384,048 million yen, record pre-tax profit of 95,938 million yen and record profit for the term of 74,824 million yen.

Hoya’s Life Care segment posted sales of 242 million yen for the non-month period, up 7.2 percent over year-ago.

“Some weak businesses in the Information Technology segment seem to have hit the bottom, and we expect that growth in the Life Care segment will drive the group performance in the coming year,” said Hiroshi Suzuki, chief executive officer of Hoya. “There is a great potential in the medical endoscope business and we will aggressively seek the opportunity for M&A.”